What is the address of DR VINCENT VANHAUDENARDE ONCOLOGIE?

The registered office of DR VINCENT VANHAUDENARDE ONCOLOGIE is located at Rue du Bourgmestre Orban 570 box A, 5300 Andenne.

Is DR VINCENT VANHAUDENARDE ONCOLOGIE still active?

Yes. According to the CBE (29 September 2026) DR VINCENT VANHAUDENARDE ONCOLOGIE is active, legal situation “Normale toestand”, started on 6 December 2012.

Is DR VINCENT VANHAUDENARDE ONCOLOGIE registered on Peppol?

No, DR VINCENT VANHAUDENARDE ONCOLOGIE is currently not registered on the Peppol network.

What is the enterprise number of DR VINCENT VANHAUDENARDE ONCOLOGIE?

The enterprise number of DR VINCENT VANHAUDENARDE ONCOLOGIE is BE0501783869.

When was DR VINCENT VANHAUDENARDE ONCOLOGIE founded?

DR VINCENT VANHAUDENARDE ONCOLOGIE was founded on 6 December 2012.

Who are the directors of DR VINCENT VANHAUDENARDE ONCOLOGIE?

According to the 2024 annual accounts, the directors of DR VINCENT VANHAUDENARDE ONCOLOGIE are: VINCENT VANHAUDENARDE.

Is DR VINCENT VANHAUDENARDE ONCOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 December 2012; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did DR VINCENT VANHAUDENARDE ONCOLOGIE make in 2024?

DR VINCENT VANHAUDENARDE ONCOLOGIE posted a profit after taxes of € 76,373 in financial year 2024.

What is the revenue of DR VINCENT VANHAUDENARDE ONCOLOGIE?

As a small company, DR VINCENT VANHAUDENARDE ONCOLOGIE is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 172,431.

DR VINCENT VANHAUDENARDE ONCOLOGIE (Private Limited)

Dossier DR VINCENT VANHAUDENARDE ONCOLOGIE, printed on 29 September 2026 from databakkes.be/en/0501783869/dr-vincent-vanhaudenarde-oncologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

DR VINCENT VANHAUDENARDE ONCOLOGIE from Andenne, company number BE0501783869, closed financial year 2024 with a result of € 76,373 after tax. For that financial year DR VINCENT VANHAUDENARDE ONCOLOGIE recorded a gross margin of € 172,431 and equity of € 271,897. Compared with financial year 2023, the result moved from € -8,603 to € 76,373. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.

What it is worth Healthy

€ 271,897

▼ 14% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 76,373

▲ still € 8,603 loss in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 116,313

▼ 3% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 120,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,864

▼ 5% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 13,575

▲ 226% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 69,089 Gross margin 2021: € 69,089 First fiscal year in the series	€ 183,235 Gross margin 2022: € 183,235 ▲ 165% vs 2021 (€ 69,089) Favourable step	€ 98,118 Gross margin 2023: € 98,118 ▼ 46% vs 2022 (€ 183,235) Unfavourable step	€ 172,431 Gross margin 2024: € 172,431 ▲ 76% vs 2023 (€ 98,118) Favourable step	▲ 76%
Profit after taxes	€ 46,333 Profit after taxes 2021: € 46,333 First fiscal year in the series	€ 64,031 Profit after taxes 2022: € 64,031 ▲ 38% vs 2021 (€ 46,333) Favourable step	€ -8,603 Profit after taxes 2023: € -8,603 ▼ € 72,634 vs 2022 (€ 64,031) Unfavourable step	€ 76,373 Profit after taxes 2024: € 76,373 ▲ € 84,976 vs 2023 (€ -8,603) Favourable step	▲ € 84,976
Equity	€ 339,496 Equity 2021: € 339,496 First fiscal year in the series	€ 324,127 Equity 2022: € 324,127 ▼ 5% vs 2021 (€ 339,496) Unfavourable step	€ 315,524 Equity 2023: € 315,524 ▼ 3% vs 2022 (€ 324,127) Unfavourable step	€ 271,897 Equity 2024: € 271,897 ▼ 14% vs 2023 (€ 315,524) Unfavourable step	▼ 14%
Total debts	€ 13,237 Total debts 2021: € 13,237 First fiscal year in the series	€ 87,656 Total debts 2022: € 87,656 ▲ € 74,418 vs 2021 (€ 13,237) Unfavourable step	€ 10,635 Total debts 2023: € 10,635 ▼ 88% vs 2022 (€ 87,656) Favourable step	€ 79,440 Total debts 2024: € 79,440 ▲ € 68,805 vs 2023 (€ 10,635) Unfavourable step	▲ € 68,805
Cash	€ 160,553 Cash 2021: € 160,553 First fiscal year in the series	€ 214,836 Cash 2022: € 214,836 ▲ 34% vs 2021 (€ 160,553) Favourable step	€ 119,762 Cash 2023: € 119,762 ▼ 44% vs 2022 (€ 214,836) Unfavourable step	€ 116,313 Cash 2024: € 116,313 ▼ 3% vs 2023 (€ 119,762) Unfavourable step	▼ 3%
Retained profit	€ 327,096 Retained profit 2021: € 327,096 First fiscal year in the series	€ 311,727 Retained profit 2022: € 311,727 ▼ 5% vs 2021 (€ 327,096) Unfavourable step	€ 303,124 Retained profit 2023: € 303,124 ▼ 3% vs 2022 (€ 311,727) Unfavourable step	€ 259,497 Retained profit 2024: € 259,497 ▼ 14% vs 2023 (€ 303,124) Unfavourable step	▼ 14%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 79,400 Dividend 2022: € 79,400 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 79,400) Unchanged	€ 120,000 Dividend 2024: € 120,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 352,733 Balance sheet total 2021: € 352,733 First fiscal year in the series	€ 411,782 Balance sheet total 2022: € 411,782 ▲ 17% vs 2021 (€ 352,733) Unchanged	€ 326,159 Balance sheet total 2023: € 326,159 ▼ 21% vs 2022 (€ 411,782) Unchanged	€ 351,337 Balance sheet total 2024: € 351,337 ▲ 8% vs 2023 (€ 326,159) Unchanged	▲ 8%

Key figures of DR VINCENT VANHAUDENARDE ONCOLOGIE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to DR VINCENT VANHAUDENARDE ONCOLOGIE?

What happened at DR VINCENT VANHAUDENARDE ONCOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2025 New annual accounts for financial year 2024: profit of € 76,373. filed late Source: NBB ↗
Jan 1, 2016 New establishment in Andenne. KBO
Dec 6, 2012 New establishment in Charleroi. KBO
Dec 6, 2012 Start of the company according to the CBE. KBO

In short

From € 46,333 profit in 2021 to € 76,373 profit in 2024.

Paid € 81,419 in corporate taxes since 2021.

Best year ever: 2024, with € 76,373 profit.

Paid out € 199,400 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR VINCENT VANHAUDENARDE ONCOLOGIE? We notify you, reason included.

Follow DR VINCENT VANHAUDENARDE ONCOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

VINCENT VANHAUDENARDE

DR VINCENT VANHAUDENARDE ONCOLOGIE

Behind DR VINCENT VANHAUDENARDE ONCOLOGIE is VINCENT VANHAUDENARDE.

See the full network in the app

Directors

According to the 2024 annual accounts

VINCENT VANHAUDENARDE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Bourgmestre Orban 570 box A

5300 Andenne

2.258.608.772

Rue du Bourgmestre Orban 57. box A

5300 Andenne

Active since 1 January 2016

2.215.091.505

Boulevard Joseph II 20

6000 Charleroi

Active since 6 December 2012

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0501.783.869
VAT number: BE 0501.783.869
Registered office: Rue du Bourgmestre Orban 570 bus A, 5300 Andenne
Names & denominations: DR VINCENT VANHAUDENARDE ONCOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 December 2012
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗